IE81316B1 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
IE81316B1
IE81316B1 IE940083A IE940083A IE81316B1 IE 81316 B1 IE81316 B1 IE 81316B1 IE 940083 A IE940083 A IE 940083A IE 940083 A IE940083 A IE 940083A IE 81316 B1 IE81316 B1 IE 81316B1
Authority
IE
Ireland
Prior art keywords
active agent
polymer
skin
pharmacologically active
penetration
Prior art date
Application number
IE940083A
Other languages
English (en)
Other versions
IE940083L (en
Inventor
Thomas Kissel
Henriette Schrank
Hans-Rainer Hoffmann
Original Assignee
Novartis Ag
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Lohmann Therapie Syst Lts filed Critical Novartis Ag
Publication of IE940083L publication Critical patent/IE940083L/en
Publication of IE81316B1 publication Critical patent/IE81316B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
IE940083A 1984-03-01 1985-02-28 Pharmaceutical compositions IE81316B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH100884 1984-03-01
CH175384 1984-04-06

Publications (2)

Publication Number Publication Date
IE940083L IE940083L (en) 1985-09-01
IE81316B1 true IE81316B1 (en) 2000-09-20

Family

ID=25686369

Family Applications (2)

Application Number Title Priority Date Filing Date
IE940083A IE81316B1 (en) 1984-03-01 1985-02-28 Pharmaceutical compositions
IE49385A IE61754B1 (en) 1984-03-01 1985-02-28 Pharmaceutical compositions

Family Applications After (1)

Application Number Title Priority Date Filing Date
IE49385A IE61754B1 (en) 1984-03-01 1985-02-28 Pharmaceutical compositions

Country Status (18)

Country Link
EP (3) EP0315218B1 (OSRAM)
JP (2) JPH0667835B2 (OSRAM)
KR (1) KR920010392B1 (OSRAM)
AT (3) ATE89750T1 (OSRAM)
AU (2) AU578275B2 (OSRAM)
CA (1) CA1257837A (OSRAM)
DE (4) DE3587698T2 (OSRAM)
DK (2) DK175774B1 (OSRAM)
GR (1) GR850507B (OSRAM)
HK (2) HK157896A (OSRAM)
HU (1) HU197847B (OSRAM)
IE (2) IE81316B1 (OSRAM)
IL (1) IL74446A (OSRAM)
MY (1) MY101919A (OSRAM)
NZ (1) NZ211248A (OSRAM)
PH (1) PH24392A (OSRAM)
PT (1) PT80033B (OSRAM)
WO (1) WO1985003878A1 (OSRAM)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU197847B (en) * 1984-03-01 1989-06-28 Sandoz Ag Process for producing therapeutical preparations suitable for transdermatic treating
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
NL8701335A (nl) * 1986-06-21 1988-01-18 Sandoz Ag Orale farmaceutische preparaten.
DE3643987A1 (de) * 1986-12-22 1988-06-23 Lohmann Therapie Syst Lts Basische, wirkstoffdurchlaessige haftklebende polymermasse, insbesondere zum einsatz mit basischen wirkstoffen, verfahren zu ihrer herstellung und ihre verwendung
DE3805744C2 (de) * 1987-03-04 1999-09-23 Novartis Ag Phenylcarbamate zur Hemmung der Acetylcholinesterase
DE3901551A1 (de) * 1989-01-20 1990-07-26 Lohmann Therapie Syst Lts Superfizielles therapeutisches system mit einem gehalt an einem antineoplastischen wirkstoff, insbesondere 5-fluoruracil
DE4020144A1 (de) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen
DE4116912A1 (de) * 1991-05-18 1992-11-26 Schering Ag Mittel zur transdermalen applikation enthaltend ergolin-derivate
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
AU4613796A (en) * 1995-02-10 1996-08-27 Jorg Kreuter Medicament in particle form
US6165988A (en) * 1995-02-10 2000-12-26 Christian Noe Medicament in particulate form
US7150881B2 (en) 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
DE19950066A1 (de) * 1999-10-16 2001-04-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einem Gehalt an Tulobuterol-hydrochlorid zur Verabreichung des Bronchodilatators Tulobuterol über die Haut
EP1170006B8 (en) * 1999-12-14 2008-03-19 Teikoku Seiyaku Co., Ltd. Drug for alleviating migraine
DE10011447A1 (de) * 2000-03-10 2001-09-20 Roehm Gmbh Dispersion mit nichtionischem Emulgator
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
DE10053397A1 (de) 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
JP5758290B2 (ja) * 2009-05-01 2015-08-05 久光製薬株式会社 経皮吸収型製剤
KR101690765B1 (ko) * 2015-04-17 2016-12-28 동아제약 주식회사 항진균성 활성물질을 포함하는 경피 제제
WO2017037812A1 (ja) * 2015-08-29 2017-03-09 株式会社メドレックス 酸捕捉剤を含有する貼付製剤
WO2018199018A1 (ja) * 2017-04-26 2018-11-01 ニプロ株式会社 経皮吸収型製剤およびその製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH653256A5 (en) * 1981-04-06 1985-12-31 Sandoz Ag Microemulsion for cutaneous use
FR2502951B1 (fr) * 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
WO1983000092A1 (en) * 1981-07-08 1983-01-20 Key Pharma Polymeric diffusion matrix containing propranolol
CH653550A5 (de) * 1981-10-20 1986-01-15 Sandoz Ag Pharmazeutische zusammensetzung zur verzoegerten freigabe eines medikamentes im mundbereich.
JPS5925320A (ja) * 1982-08-02 1984-02-09 Watanabe Yakuhin Kogyo Kk 薬物投与用貼付剤
HU197847B (en) * 1984-03-01 1989-06-28 Sandoz Ag Process for producing therapeutical preparations suitable for transdermatic treating

Also Published As

Publication number Publication date
DK502985A (da) 1985-10-31
WO1985003878A1 (en) 1985-09-12
DK175774B1 (da) 2005-02-14
AU607496B2 (en) 1991-03-07
IE850493L (en) 1985-09-01
HK157896A (en) 1996-08-30
MY101919A (en) 1992-02-15
DE3587698D1 (de) 1994-02-03
KR850700218A (ko) 1985-12-26
IE940083L (en) 1985-09-01
JPH0667835B2 (ja) 1994-08-31
EP0315218A2 (en) 1989-05-10
PT80033B (pt) 1987-10-20
IE61754B1 (en) 1994-11-30
PT80033A (en) 1985-03-01
DK164257C (da) 1992-10-19
DE3587048T2 (de) 1993-06-03
ATE103819T1 (de) 1994-04-15
DE3587048D1 (de) 1993-03-11
DE3587794T2 (de) 1994-08-04
DE3587698T2 (de) 1994-04-28
KR920010392B1 (ko) 1992-11-27
JPH0748253A (ja) 1995-02-21
EP0155229A2 (en) 1985-09-18
AU578275B2 (en) 1988-10-20
HUT41644A (en) 1987-05-28
DK164257B (da) 1992-06-01
PH24392A (en) 1990-06-13
EP0315218B1 (en) 1993-12-22
DK324687A (da) 1987-06-25
NZ211248A (en) 1988-10-28
DE3587358D1 (de) 1993-07-01
ATE98876T1 (de) 1994-01-15
ATE89750T1 (de) 1993-06-15
DK324687D0 (da) 1987-06-25
HU197847B (en) 1989-06-28
DK502985D0 (da) 1985-10-31
IL74446A (en) 1990-11-29
EP0315219B1 (en) 1993-01-27
EP0315218A3 (en) 1991-03-06
DE3587794D1 (de) 1994-05-11
EP0315219A2 (en) 1989-05-10
JPS61501324A (ja) 1986-07-03
EP0155229A3 (en) 1985-12-11
EP0315219A3 (en) 1991-03-06
IL74446A0 (en) 1985-05-31
AU4065085A (en) 1985-09-24
GR850507B (OSRAM) 1985-06-28
CA1257837A (en) 1989-07-25
AU1662688A (en) 1988-10-20
JP2540019B2 (ja) 1996-10-02
HK220096A (en) 1997-01-03
EP0155229B1 (en) 1993-05-26
DE3587358T2 (de) 1993-11-04

Similar Documents

Publication Publication Date Title
US5364628A (en) Pharmaceutical compositions
AU578275B2 (en) Pharmaceutical compositions
RU2194496C2 (ru) Нанесенный на ленту препарат для чрескожного введения, содержащий фентанил
JP4542429B2 (ja) フェンタニル経皮外用貼付剤
CZ281991B6 (cs) Způsob výroby transdermálního therapeutického systému
JPH1045570A (ja) フェンタニル含有経皮投与テープ製剤
JP4758101B2 (ja) 貼付剤
CN112915071A (zh) 一种含有美金刚的透皮贴剂
US6316023B1 (en) TTS containing an antioxidant
EP1847264A1 (en) Patch
CN113876740A (zh) 一种阿戈美拉汀的透皮贴剂
EP0315217B1 (en) Pharmaceutical compositions
DK175982B1 (da) Farmaceutisk præparat til transdermal systemisk administration af et farmakologisk aktivt middel, fremgangsmåde til fremstilling af et præparat og anvendelse af et polyacrylat til fremstilling af et lægemiddel
IE69475B1 (en) Pharmaceutical compositions
DK175236B1 (da) Farmaceutisk præparat
US20210290560A1 (en) Transdermal therapeutic system for dispensing scopolamine without a membrane
MXPA98000359A (en) A formulation of adhesive tape for cutaneous administration which contains fentan
HK1034036A1 (en) Tts containing an antioxidant
HK1034036B (en) Tts containing an antioxidant

Legal Events

Date Code Title Description
MK9A Patent expired